{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:03:13Z","timestamp":1784908993135,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.msard.2022.103739","type":"journal-article","created":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T01:16:10Z","timestamp":1647134170000},"page":"103739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["COVID-19 vaccine associated demyelination & its association with MOG antibody"],"prefix":"10.1016","volume":"60","author":[{"given":"M.","family":"Netravathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamakshi","family":"Dhamija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina","family":"Tamborska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.V.","family":"Holla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.K.","family":"Nitish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Seena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ravindranadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagteshwar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2022.103739_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/00368504211025927","article-title":"COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review of the potential mechanisms and proposed management","volume":"104","author":"Alam","year":"2021","journal-title":"Sci. Prog."},{"issue":"8","key":"10.1016\/j.msard.2022.103739_bib0023","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/01616412.2021.1915078","article-title":"Myelopathy associated with SARS-COV-2 infection. a systematic review","volume":"43","author":"Artemiadis","year":"2021","journal-title":"Neurol. Res."},{"issue":"7","key":"10.1016\/j.msard.2022.103739_bib0008","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.braindev.2016.02.004","article-title":"Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy","volume":"38","author":"Azumagawa","year":"2016","journal-title":"Brain Dev."},{"key":"10.1016\/j.msard.2022.103739_bib0006","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/jnnp-2021-326924","article-title":"Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder","volume":"92","author":"Butler","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.msard.2022.103739_bib0017","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1473-3099(20)30942-7","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial","volume":"21","author":"Ella","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"0","key":"10.1016\/j.msard.2022.103739_bib0024","first-page":"1","article-title":"Spinal cord involvement in COVID-19: a review","volume":"0","author":"Garg","year":"2021","journal-title":"J. Spinal Cord. Med."},{"issue":"1","key":"10.1016\/j.msard.2022.103739_bib0011","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2249.2006.03046.x","article-title":"Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection","volume":"144","author":"Hsu","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.msard.2022.103739_bib0014","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jocn.2008.05.002","article-title":"Post-vaccination encephalomyelitis: literature review and illustrative case","volume":"15","author":"Huynh","year":"2008","journal-title":"J. Clin. Neurosci."},{"issue":"577765","key":"10.1016\/j.msard.2022.103739_bib0018","article-title":"A systematic review of cases of CNS demyelination following COVID-19 vaccination","volume":"362","author":"Ismail","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2022.103739_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","article-title":"The spectrum of post-vaccination inflammatory CNS demyelinating syndromes","volume":"13","author":"Karussis","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.msard.2022.103739_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s43055-021-00410-7","article-title":"COVID-19 associated acute demyelination masquerading as stroke: a case report","volume":"52","author":"Khandelwal","year":"2021","journal-title":"Egyptian J. Radiol. Nuclear Med."},{"issue":"2","key":"10.1016\/j.msard.2022.103739_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7224\/1537-2073.2018-104","article-title":"Case Report: postvaccination Anti\u2013Myelin Oligodendrocyte Glycoprotein Neuromyelitis Optica Spectrum Disorder","volume":"22","author":"Kumar","year":"2020","journal-title":"Int. J. MS Care"},{"issue":"10275","key":"10.1016\/j.msard.2022.103739_bib0002","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet North Am. Ed."},{"issue":"2","key":"10.1016\/j.msard.2022.103739_bib0004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.26143","article-title":"Guillain-Barr\u00e9 Syndrome following ChAdOx1-S\/nCoV-19 Vaccine","volume":"90","author":"Maramattom","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2022.103739_bib0016","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2147\/IDR.S315727","article-title":"Overview of the Main Anti-SARS-CoV-2 Vaccines: mechanism of Action, Efficacy and Safety","volume":"14","author":"Mascellino","year":"2021","journal-title":"Infect. Drug Resist"},{"issue":"577523","key":"10.1016\/j.msard.2022.103739_bib0026","article-title":"Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: a case report and review of literature","volume":"353","author":"Moreno-Escobar","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"577606","key":"10.1016\/j.msard.2022.103739_bib0029","article-title":"A case of longitudinally extensive transverse myelitis following vaccination against Covid-19","volume":"358","author":"Pagenkopf","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"30","key":"10.1016\/j.msard.2022.103739_bib0019","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.vaccine.2005.03.005","article-title":"Consequence or coincidence? The occurrence, pathogenesis, and significance of autoimmune manifestations after viral vaccines","volume":"23","author":"Schattner","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.msard.2022.103739_bib0028","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/qjmed\/hcab069","article-title":"COVID-19 vaccination-associated myelitis","volume":"114","author":"Singh Malhotra","year":"2021","journal-title":"QJM: Int. J. Med."},{"issue":"10","key":"10.1016\/j.msard.2022.103739_bib0021","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological Features of Covid-19","volume":"383","author":"Solomon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2022.103739_bib0022","volume":"06","author":"Song","year":"2020"},{"key":"10.1016\/j.msard.2022.103739_bib0013","first-page":"93","article-title":"Autoantibodies Induced by Vaccine","volume":"DOI","author":"Toplak","year":"2015"},{"key":"10.1016\/j.msard.2022.103739_bib0012","series-title":"Dermatological Signs of Internal Disease (Fourth Edition)","first-page":"11","article-title":"Chapter 2 - Dermatomyositis","author":"Vleugels","year":"2009"},{"issue":"10269","key":"10.1016\/j.msard.2022.103739_bib0001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet North Am. Ed."},{"issue":"2","key":"10.1016\/j.msard.2022.103739_bib0005","first-page":"e13426","article-title":"Neurological Complications of COVID-19: guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine","volume":"13","author":"Waheed","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.msard.2022.103739_bib0010","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody disease","volume":"266","author":"Wynford-Thomas","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103739_bib0027","series-title":"SARS-CoV-2 Can Induce Brain and Spine Demyelinating Lesions","first-page":"1","author":"Zanin","year":"2020"},{"issue":"5","key":"10.1016\/j.msard.2022.103739_bib0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.103739_bib0007","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WNO.0000000000001049","article-title":"Myelin Oligodendrocyte Glycoprotein Antibody\u2013Associated Optic Neuritis and Myelitis in COVID-19","volume":"40","author":"Zhou","year":"2020","journal-title":"J. Neuroophthalmol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822002541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822002541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:59:54Z","timestamp":1761901194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822002541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":29,"alternative-id":["S2211034822002541"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103739","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine associated demyelination & its association with MOG antibody","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103739"}}